1. Home
  2. SVV vs ORKA Comparison

SVV vs ORKA Comparison

Compare SVV & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Savers Value Village Inc.

SVV

Savers Value Village Inc.

HOLD

Current Price

$11.24

Market Cap

1.6B

ML Signal

HOLD

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$32.18

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVV
ORKA
Founded
1954
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SVV
ORKA
Price
$11.24
$32.18
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$13.67
$52.70
AVG Volume (30 Days)
755.8K
454.9K
Earning Date
02-19-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,616,273,000.00
N/A
Revenue This Year
$17.32
N/A
Revenue Next Year
$7.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.45
N/A
52 Week Low
$6.48
$5.49
52 Week High
$13.89
$36.51

Technical Indicators

Market Signals
Indicator
SVV
ORKA
Relative Strength Index (RSI) 53.29 54.14
Support Level $10.90 $31.00
Resistance Level $11.41 $33.89
Average True Range (ATR) 0.38 1.96
MACD -0.04 -0.28
Stochastic Oscillator 44.30 46.78

Price Performance

Historical Comparison
SVV
ORKA

About SVV Savers Value Village Inc.

Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: